PLA2G16 promotes osteosarcoma metastasis and drug resistance via the MAPK pathway

The prognosis of metastatic osteosarcoma is dismal and a better understanding of the mechanisms underlying disease progression is essential to improve treatment options and patient outcomes. We previously demonstrated Pla2g16 overexpression in mouse osteosarcoma contributes to metastasis phenotypes...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Lin, Liang, Shoulei, Wasylishen, Amanda R., Zhang, Yanqin, Yang, Xueli, Zhou, Bingzheng, Shan, Luling, Han, Xiuxin, Mu, Tianyang, Wang, Guowen, Xiong, Shunbin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951268/
https://www.ncbi.nlm.nih.gov/pubmed/26933804
http://dx.doi.org/10.18632/oncotarget.7694

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951268/
https://www.ncbi.nlm.nih.gov/pubmed/26933804
http://dx.doi.org/10.18632/oncotarget.7694

Ejemplares similares